PFBT
KRYS icon

Parkside Financial Bank & Trust’s Krystal Biotech KRYS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.78K Buy
34
+1
+3% +$266 ﹤0.01% 1631
2025
Q4 		$8.14K Buy
33
+8
+32% +$1.68K ﹤0.01% 1654
2025
Q3 		$4.42K Buy
25
+10
+67% +$1.5K ﹤0.01% 1775
2025
Q2 		$2.06K Sell
15
-6
-29% -$881 ﹤0.01% 1996
2025
Q1 		$3.79K Buy
21
+18
+600% +$3.03K ﹤0.01% 1717
2024
Q4 		$470 Buy
3
+1
+50% +$177 ﹤0.01% 1884
2024
Q3 		$365 Hold
2
– – ﹤0.01% 1888
2024
Q2 		$368 Buy
+2
New +$336 ﹤0.01% 1835

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's KRYS Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Krystal Biotech (KRYS) stake by 3% in Q1 2026, buying an estimated $266 and bringing the position to 34 shares worth $8.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

Parkside Financial Bank & Trust first reported a position in KRYS in Q2 2024 and has held it in 8 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Parkside Financial Bank & Trust held 34 shares of Krystal Biotech worth $8.78K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 1 Krystal Biotech share in Q1 2026, an estimated $266.
  • Krystal Biotech made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1631 holding.
  • Parkside Financial Bank & Trust first reported a position in Krystal Biotech in Q2 2024 and has held it in 8 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.